Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

References

• Abdi, F., Quinn, J. F., Jankovic, J., Mcintosh, M., Leverenz, J. B., Peskind, E., Nixon, R., Nutt, J., Chung, K., Zabetian, C., Samii, A., Lin, M., Hattan, S., Pan, C., Wang, Y., Jin, J., Zhu, D., Li, G. J., Liu, Y., Waichunas, D., Montine, T. J. & Zhang, J. (2006) Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis, 9, 293–348.
   PubMed Web of Science ®Google Scholar
• Amano, S., Yamagishi, S., Inagaki, Y., Nakamura, K., Takeuchi, M., Inoue, H. & Imaizumi, T. (2005) Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc Res, 69, 45–55.
   PubMed Web of Science ®Google Scholar
• Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B. & Blennow, K. (2001) Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol, 58, 373–9.
   PubMed Web of Science ®Google Scholar
• Atamna, H. & Boyle, K. (2006) Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer’s disease. Proc Natl Acad Sci U S A, 103, 3381–6.
   PubMed Web of Science ®Google Scholar
• Benjamini, Y. & Hochberg, Y. (1995) Controlling the False Discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: series B, 57, 289–300.
   Web of Science ®Google Scholar
• Bilak, M. M., Corse, A. M., Bilak, S. R., Lehar, M., Tombran-Tink, J. & Kuncl, R. W. (1999) Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol, 58, 719–28.
   PubMed Web of Science ®Google Scholar
• Biroccio, A., Del Boccio, P., Panella, M., Bernardini, S., Di Ilio, C., Gambi, D., Stanzione, P., Sacchetta, P., Bernardi, G., Martorana, A., Federici, G., Stefani, A. & Urbani, A. (2006) Differential post-translational modifications of transthyretin in Alzheimer’s disease: a study of the cerebral spinal fluid. Proteomics, 6, 2305–13.
   PubMed Web of Science ®Google Scholar
• Blennow, K. & Hampel, H. (2003) CSF markers for incipient Alzheimer’s disease. Lancet Neurol, 2, 605–13.
   PubMed Web of Science ®Google Scholar
• Bonifati, D. M. & Kishore, U. (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol, 44, 999–1010.
   PubMed Web of Science ®Google Scholar
• Buerger, K., Ewers, M., Andreasen, N., Zinkowski, R., Ishiguro, K., Vanmechelen, E., Teipel, S. J., Graz, C., Blennow, K. & Hampel, H. (2005) Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study. Neurology, 65, 1502–3.
   PubMed Web of Science ®Google Scholar
• Buerger, K., Zinkowski, R., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann-Kiefer, K., Debernardis, J., Kerkman, D., Mcculloch, C., Kohnken, R., Padberg, F., Pirttila, T., Schapiro, M. B., Rapoport, S. I., Moller, H. J., Davies, P. & Hampel, H. (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol, 59, 1267–72.
   PubMed Web of Science ®Google Scholar
• Cao, W., Tombran-Tink, J., Chen, W., Mrazek, D., Elias, R. & Mcginnis, J. F. (1999) Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res, 57, 789–800.
   PubMed Web of Science ®Google Scholar
• Castano, E. M., Roher, A. E., Esh, C. L., Kokjohn, T. A. & Beach, T. (2006) Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer’s disease and non-demented elderly subjects. Neurol Res, 28, 155–63.
   PubMed Web of Science ®Google Scholar
• Chen, C. & Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol, 7, 2745–52.
   PubMed Web of Science ®Google Scholar
• Chuu, J. Y., Taylor, J. L., Tinklenberg, J., Noda, A., Yesavage, J. & Murphy, G. M. JR. (2006) The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer’s disease. J Alzheimers Dis, 9, 43–9.
   Google Scholar
• Clark, C. M., Xie, S., Chittams, J., Ewbank, D., Peskind, E., Galasko, D., Morris, J. C., Mckeel, D. W., Jr., Farlow, M., Weitlauf, S. L., Quinn, J., Kaye, J., Knopman, D., Arai, H., Doody, R. S., Decarli, C., Leight, S., Lee, V. M. & Trojanowski, J. Q. (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol, 60, 1696–702.
   PubMed Web of Science ®Google Scholar
• Delong, E. R., Delong, D. M. & Clarke-Pearson, D. L. (1988) Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach. Biometrics, 44, 837–845.
   PubMed Web of Science ®Google Scholar
• Diniz, B. S., Pinto Junior, J. A. & Forlenza, O. V. (2008) Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer’s disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry, 9, 172–82.
   PubMed Web of Science ®Google Scholar
• Dreja, H., Gros, L., Villard, S., Bachrach, E., Oates, A., Granier, C., Chardes, T., Mani, J. C., Piechaczyk, M. & Pelegrin, M. (2003) Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor. J Virol, 77, 10984–93.
   Google Scholar
• Efron, B. (1979) Bootstrap Methods: Another Look at the Jackknife. Annals of Statistic, 7, 1–26.
   Web of Science ®Google Scholar
• Franciosi, S., Choi, H. B., Kim, S. U. & Mclarnon, J. G. (2005) IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia. J Neuroimmunol, 159, 66–74.
   PubMed Web of Science ®Google Scholar
• Ge, Y., Dudoit, S. & Speed, T. P. (2003) Resampling-based multiple testing for microarray data hypothesis. Sociedad de estadistica e investigacion operativa test, 12, 1–77.
   Google Scholar
• Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J. Y. & Zhang, J. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol, 5, R80.
   PubMed Web of Science ®Google Scholar
• Griffin, W. S., Liu, L., Li, Y., Mrak, R. E. & Barger, S. W. (2006) Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation, 3, 5.
   PubMed Web of Science ®Google Scholar
• Gu, F., Zhu, M., Shi, J., Hu, Y. & Zhao, Z. (2008) Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice. Neurosci Lett, 440, 44–8.
   PubMed Web of Science ®Google Scholar
• Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., Debernardis, J., Kerkman, D., Ishiguro, K., Ohno, H., Vanmechelen, E., Vanderstichele, H., Mcculloch, C., Moller, H. J., Davies, P. & Blennow, K. (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry, 61, 95–102.
   PubMed Web of Science ®Google Scholar
• Hanley, J. A. & Mcneil, B. J. (1983) A method of Comparing the areas under Receiver Operating Characteristic Curves Derived from the Same Cases. Radiology, 148, 839–843.
   PubMed Web of Science ®Google Scholar
• Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K. & Minthon, L. (2006) Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol, 5, 228–34.
   PubMed Web of Science ®Google Scholar
• Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. & Martin, R. L. (1982) A new clinical scale for the staging of dementia. Br J Psychiatry, 140, 566–72.
   PubMed Web of Science ®Google Scholar
• Johnson, G., Brane, D., Block, W., Van Kammen, D. P., Gurklis, J., Peters, J. L., Wyatt, R. J., Kirch, D. G., Ghanbari, H. A. & Merril, C. R. (1992) Cerebrospinal fluid protein variations in common to Alzheimer’s disease and schizophrenia. Appl Theor Electrophor, 3, 47–53.
   PubMedGoogle Scholar
• Kazim, A. L. & Atassi, M. Z. (1981) Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin. Biochem J, 197, 507–10.
   Google Scholar
• Kohler, G., Howe, S. C. & Milstein, C. (1976) Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol, 6, 292–5.
   PubMed Web of Science ®Google Scholar
• Laune, D., Molina, F., Ferrieres, G., Villard, S., Bes, C., Rieunier, F., Chardes, T. & Granier, C. (2002) Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding. J Immunol Methods, 267, 53–70.
   PubMed Web of Science ®Google Scholar
• Maik-Rachline, G. & Seger, R. (2006) Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function. Blood, 107, 2745–52.
   PubMed Web of Science ®Google Scholar
• MAIK-RACHLINE, G., SHALTIEL, S. & SEGER, R. (2005) Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood, 105, 670–8.
   PubMed Web of Science ®Google Scholar
• Maria, W. S., Velarde, D. T., Alvarenga, L. M., Nguyen, C., Villard, S., Granier, C. & Chavez-Olortegui, C. (2005) Localization of epitopes in the toxins of Tityus serrulatus scorpions and neutralizing potential of therapeutic antivenoms. Toxicon, 46, 210–7.
   Google Scholar
• Mattila, K. M., Pirttila, T., Blennow, K., Wallin, A., Viitanen, M. & Frey, H. (1994) Altered blood-brain-barrier function in Alzheimer’s disease? Acta Neurol Scand, 89, 192–8.
   PubMed Web of Science ®Google Scholar
• Molina, L., Touchon, J., Herpe, M., Lefranc, D., Duplan, L., Cristol, J. P., Sabatier, R., Vermersch, P., Pau, B. & Mourton-Gilles, C. (1999) Tau and apo E in CSF: potential aid for discriminating Alzheimer’s disease from other dementias. Neuroreport, 10, 3491–5.
   PubMed Web of Science ®Google Scholar
• Motter, R., Vigo-Pelfrey, C., Kholodenko, D., Barbour, R., Johnson-Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R. & et al. (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol, 38, 643–8.
   PubMed Web of Science ®Google Scholar
• Nakamura, S., Arima, K., Haga, S., Aizawa, T., Motoi, Y., Otsuka, M., Ueki, A. & Ikeda, K. (1998) Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques. Brain Res, 814, 222–5.
   PubMedGoogle Scholar
• Namba, T., Yabe, T., Gonda, Y., Ichikawa, N., Sanagi, T., Arikawa-Hirasawa, E., Mochizuki, H., Kohsaka, S. & Uchino, S. (2010) Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-d-aspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells. Neuroscience, 167, 372–83.
   PubMed Web of Science ®Google Scholar
• O’brien, M. D. (1988) Vascular dementia is underdiagnosed. Arch Neurol, 45, 797–8.
   PubMedGoogle Scholar
• Petersen, S. V., Valnickova, Z. & Enghild, J. J. (2003) Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J, 374, 199–206.
   PubMed Web of Science ®Google Scholar
• Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N., Blennow, K. & Davidsson, P. (2003) Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer’s disease. Brain Res Mol Brain Res, 118, 140–6.
   PubMedGoogle Scholar
• Riemenschneider, M., Schwarz, S., Wagenpfeil, S., Diehl, J., Muller, U., Forstl, H. & Kurz, A. (2002) A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer’s disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry, 7, 782–5.
   PubMed Web of Science ®Google Scholar
• Roher, A. E., Maarouf, C. L., Sue, L. I., Hu, Y., Wilson, J. & Beach, T. G. (2009) Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease. Biomarkers, 14, 493–501.
   PubMed Web of Science ®Google Scholar
• Sanchez, D. J., Armstrong, L., Aguilar, R., Adrian, G. S., Haro, L. & Martinez, A. O. (2001) Haptoglobin gene expression in human glioblastoma cell lines. Neurosci Lett, 303, 181–4.
   PubMed Web of Science ®Google Scholar
• Simonsen, A. H., Mcguire, J., Podust, V. N., Davies, H., Minthon, L., Skoog, I., Andreasen, N., Wallin, A., Waldemar, G. & Blennow, K. (2008) Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer’s disease. Neurobiol Aging, 29, 961–8.
   PubMed Web of Science ®Google Scholar
• Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A. & Seshadri, S. (2007) Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology, 68, 1902–8.
   PubMed Web of Science ®Google Scholar
• Thirumangalakudi, L., Samany, P. G., Owoso, A., Wiskar, B. & Grammas, P. (2006) Angiogenic proteins are expressed by brain blood vessels in Alzheimer’s disease. J Alzheimers Dis, 10, 111–8.
   PubMedGoogle Scholar
• Tombran-Tink, J. & Barnstable, C. J. (2003) PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci, 4, 628–36.
   PubMed Web of Science ®Google Scholar
• Tseng, C. F., Lin, C. C., Huang, H. Y., Liu, H. C. & Mao, S. J. (2004) Antioxidant role of human haptoglobin. Proteomics, 4, 2221–8.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe, H., Langlois, M. & Delanghe, J. (2004) Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta, 345, 35–42.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe, H., Langlois, M., Delanghe, J., Horsmans, Y., Michielsen, P., Henrion, J., Cartuyvels, R., Billiet, J., De Vos, M. & Leroux-Roels, G. (2001) Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol, 35, 707–11.
   PubMed Web of Science ®Google Scholar
• Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., Van De Voorde, A., Martin, J. J. & Cras, P. (1993) Detection of tau proteins in normal and Alzheimer’s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem, 61, 1828–34.
   PubMed Web of Science ®Google Scholar
• Vanderstichele, H., De Vreese, K., Blennow, K., Andreasen, N., Sindic, C., Ivanoiu, A., Hampel, H., Burger, K., Parnetti, L., Lanari, A., Padovani, A., Diluca, M., Blaser, M., Olsson, A. O., Pottel, H., Hulstaert, F. & Vanmechelen, E. (2006) Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer’s disease and dementia with Lewy bodies. Clin Chem Lab Med, 44, 1472–80.
   PubMed Web of Science ®Google Scholar
• Verdier, J. (2007) Method for the differential diagnosis and the monitoring of Alzheimer-type dementia. IN INSERM (Ed.) World Intellectual Property Organization. WO/2007/042897. G01N 33/68 ed. France.
   Google Scholar
• Wang, H. (2007) A note on iterative marginal optimization: a simple algorithm for maximum rank correlation etimation. Computational statistical and data analysis, 51, 2803–2812.
   Web of Science ®Google Scholar
• Wisniewski, H. M. & Wegiel, J. (1995) The neuropathology of Alzheimer’s disease. Neuroimaging Clin N Am, 5, 45–57.
   Google Scholar
• Wu, C. W., Liao, P. C., Yu, L., Wang, S. T., Chen, S. T., Wu, C. M. & Kuo, Y. M. (2004) Hemoglobin promotes Abeta oligomer formation and localizes in neurons and amyloid deposits. Neurobiol Dis, 17, 367–77.
   Google Scholar
• Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., Mcconlogue, L., Masliah, E. & Mucke, L. (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med, 7, 612–8.
   PubMed Web of Science ®Google Scholar
• Yamagishi, S., Inagaki, Y., Takeuchi, M. & Sasaki, N. (2004) Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer’s disease? Med Hypotheses, 63, 115–7.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., Aebersold, R. H. & Montine, T. J. (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis, 7, 125–33; discussion 173-80.
   PubMed Web of Science ®Google Scholar